Addison's Disease: A Comprehensive Reference in Nutrition and Natural Health Context
1. Definition and Overview
Addison's disease, also known as primary adrenal insufficiency, is a rare long-term endocrine disorder characterized by inadequate production of the steroid hormones cortisol and aldosterone by the two outer layers of the cells of the adrenal glands (adrenal cortex), causing adrenal insufficiency. The disease results from the destruction of the bilateral adrenal cortex, leading to decreased adrenocortical hormones, including cortisol, aldosterone, and androgens.
The onset of disease usually occurs when 90% or more of both adrenal cortices are dysfunctional or destroyed. Thomas Addison first described the clinical presentation of primary adrenocortical insufficiency in 1855 in his classic paper, On the Constitutional and Local Effects of Disease of the Supra-Renal Capsules.
Addison's disease is rare, with an incidence of approximately 0.6 per 100,000 of the population annually. The total number of people affected at a given time ranges from 4 to 11 per 100,000 of the population. In adults, the typical age of presentation is 30 to 50 years and it is more frequently seen in women.
2. Body Systems Involved
Primary adrenal insufficiency is a potentially life-threatening condition that demonstrates the vital role of glucocorticoid and mineralocorticoid hormones in maintaining the homeostasis of energy, electrolytes, and body fluids.
The following body systems are directly implicated:
- Endocrine system: Cortisol helps regulate metabolism, manage stress responses, control blood pressure, and reduce inflammation. Aldosterone is essential for maintaining the balance of sodium and potassium in the body, which in turn regulates blood pressure and fluid balance.
- Immune system: In autoimmune Addison's disease, an immune response is triggered by a normal adrenal gland protein, typically 21-hydroxylase. This protein plays a key role in producing certain hormones in the adrenal glands. The prolonged immune attack triggered by 21-hydroxylase damages the adrenal glands, specifically the outer layers known as the adrenal cortex, preventing hormone production.
- Cardiovascular system: Under certain circumstances, an adrenal crisis may occur with low blood pressure, vomiting, lower back pain, and loss of consciousness.
- Metabolic system: Hypoglycemia in Addison's disease results from inadequate cortisol levels, which play a crucial role in maintaining blood glucose homeostasis. Cortisol stimulates gluconeogenesis, glycogenolysis, and lipolysis, ensuring a constant supply of glucose for energy production. In Addison's disease, cortisol deficiency impairs these processes, leading to decreased glucose production and increased glucose utilization, predisposing individuals to hypoglycemia, especially during fasting or stress.
- Skeletal system: Addison's disease is associated with low bone mineral density and increased risk of hip fractures. Causes are multifactorial, contributed by underlying adrenocortical hormonal deficiency, associated autoimmune endocrinopathies, electrolyte disturbances and, in some patients, supraphysiologic glucocorticoid replacement.
- Psychological/neurological system: Patients with Addison's disease have relatively high rates of depression and anxiety symptoms compared with population-based reference samples.
3. Clinical Presentation and Symptoms
Addison's disease's insidious course of action usually presents with glucocorticoid deficiency followed by mineralocorticoid deficiency. However, the condition can also present acutely, often triggered by intercurrent illness.
The most common symptoms include:
- Steadily worsening fatigue (most common symptom); patches of dark skin (hyperpigmentation), especially around scars, skin creases, and gums; abdominal pain; nausea and vomiting; loss of appetite and unintentional weight loss; muscle pain, muscle spasms, and/or joint pain; dehydration; low blood pressure, which can cause lightheadedness or dizziness upon standing; changes in mood and behavior, such as irritability, depression, and poor concentration; a craving for salty food; and low blood sugar (hypoglycemia).
Darkening (hyperpigmentation) of the skin, including areas not exposed to the sun β characteristic sites of darkening are skin creases (e.g., of the hands), nipple, and the inside of the cheek (buccal mucosa); also, old scars may darken. The subunit ACTH undergoes further cleavage to produce alpha-MSH, the most important MSH for skin pigmentation. In secondary and tertiary forms of adrenal insufficiency, skin darkening does not occur, as ACTH is not overproduced.
Adrenal Crisis: An "adrenal crisis" or "Addisonian crisis" is a constellation of symptoms that indicates severe adrenal insufficiency. This may be the result of either previously undiagnosed Addison's disease, a disease process suddenly affecting adrenal function (such as adrenal hemorrhage), or an intercurrent problem (e.g., infection, trauma) in someone known to have the condition.
4. Contributing and Associated Factors
4.1 Autoimmune Etiology
Most cases of Addison's disease are caused by the gradual destruction of the adrenal cortex, the outer layer of the adrenal glands, by the body's own immune system. About 70 percent of reported cases of Addison's disease are due to autoimmune disorders, in which the immune system makes antibodies that attack the body's own tissues or organs and slowly destroy them.
Adrenal insufficiency occurs when at least 90 percent of the adrenal cortex has been destroyed. As a result, often both glucocorticoid and mineralocorticoid hormones are lacking.
4.2 Genetic and Immunogenetic Factors
The genes that have been associated with autoimmune Addison disease participate in the body's immune response. The most commonly associated genes belong to a family of genes called the human leukocyte antigen (HLA) complex. The HLA complex helps the immune system distinguish the body's own proteins from proteins made by foreign invaders such as viruses and bacteria. The most well-known risk factor for autoimmune Addison disease is a variant of the HLA-DRB1 gene called HLA-DRB1*04:04. This and other disease-associated HLA gene variants likely contribute to an inappropriate immune response that leads to autoimmune Addison disease, although the mechanism is unknown.
4.3 Infectious Causes
Tuberculosis (TB) is the most common cause of Addison's disease worldwide. Infectious etiologies include sepsis, tuberculosis, cytomegalovirus, and HIV. The prevalence of tuberculosis has declined, but HIV has emerged as the most important cause of adrenal insufficiency associated with adrenal necrosis. Other infectious causes include disseminated fungal infections, histoplasmosis, and syphilis.
4.4 Other Causes
Other conditions that may cause primary adrenocortical insufficiency in addition to autoimmunity include infections, genetic disorders, malignancy, medication, and critical illness. Rarely, Addison's disease can be caused by a genetic disorder, or by adrenal cancer. Certain medicines like antifungal medicines can also trigger the condition.
4.5 Autoimmune Polyglandular Syndromes
Approximately 75% of cases of Addison's disease are due to an autoimmune attack. Autoimmune Addison's disease may happen by itself or as part of a rare, inherited syndrome, specifically autoimmune polyendocrine syndromes I (APS type-1) and II (Schmidt syndrome). Autoimmune primary adrenal insufficiency can appear as an isolated manifestation but is in more than 60% of cases seen concomitantly with other autoimmune disorders in autoimmune polyglandular syndromes (APS). A recent study comprising more than 22 million persons in the United Kingdom revealed an increased risk of autoimmune primary adrenal insufficiency connected with almost any other autoimmune disease, either linked to joint genetic risk factors, or the commonly used treatment for several autoimmune disorders with high doses of glucocorticoids.
Up to 50% of people with Addison's disease develop another autoimmune condition. You may also be at increased risk if you have another autoimmune condition, such as Type 1 diabetes, Graves' disease, or pernicious anemia.
5. Nutritional Considerations and Deficiencies
5.1 Electrolytes: Sodium and Potassium
Aldosterone helps regulate the body's sodium and potassium balance. When aldosterone is low, the body may lose excessive sodium, leading to low blood pressure (hypotension), fatigue, dizziness, nausea, and salt cravings.
The lack of aldosterone leads to losing too much sodium and keeping too much potassium. This balance is important for nerve and muscle function, staying hydrated, and keeping the body's pH level right.
The relationship between dietary sodium intake and disease management has been recognized clinically for many decades. In cases of severe Addison's disease, suprarenal insufficiency has developed in spite of an adequate intake of sodium chloride and liberal use of a cortical hormone of proved potency, pointing to the existence of one or more unknown factors which influenced unfavorably the course of the disease. Early clinical observations noted that patients who consumed generous quantities of sodium-containing compounds had, in some cases, preserved their weight and strength for years without other treatment. Doctors do not prescribe a single specific diet for all individuals with Addison's disease. Instead, dietary recommendations aim to manage electrolyte imbalances and adapt to increased cortisol and aldosterone needs during times of illness or stress.
5.2 Blood Glucose and Carbohydrate Metabolism
Hypoglycemia can be a symptom in patients with Addison's disease. The common regimen of replacement therapy with oral glucocorticoids results in unphysiological low cortisol levels in the early morning, the time of highest insulin sensitivity. Therefore patients with Addison's disease are at risk for unrecognized and potentially severe nocturnal hypoglycemia.
A published case report in a peer-reviewed journal described a patient with Addison's disease with nocturnal hypoglycemia identified on continuous glucose monitoring. The hypoglycemia resolved with a late evening dietary supplement with attendant improvement in morning fatigue and headache. This problem may be more frequent than recognized and a systematic study is required. Dietary manipulation to address the hypoglycemia was attempted and the patient was advised to have an evening low glycaemic index (GI) snack incorporating a fat load.
Several factors can precipitate hypoglycemia in individuals with Addison's disease, including prolonged fasting or skipping meals, which exacerbates glucose depletion; physiological or psychological stressors such as illness, surgery, trauma, or emotional distress; and intense or prolonged physical activity, which increases glucose utilization.
5.3 Bone Health: Calcium and Vitamin D
Steroids can cause a decrease in bone density and put patients at risk for weak bones and osteoporosis. To counteract this, it is considered important to consume foods high in calcium and vitamin D.
A study examining vertebral bone mineral density in 30 patients diagnosed with Addison's disease over 12 months found that bone mineral density in premenopausal women and men with Addison's disease was similar to healthy controls and postmenopausal women had slightly lower results. Rate of change of bone density followed up over a period of 12 months was β0.82%, and bone loss was not influenced by duration or type of steroid treatment.
A 2022 systematic review published in Frontiers in Endocrinology examined vitamin D's relationship to adrenal diseases. Several studies demonstrate possible correlations between vitamin D and Addison's disease, Cushing disease, hyperaldosteronism, or adrenocortical tumors, and the vitamin D hormone and adrenal gland even seem to be deeply connected by common genetic pathways.
A study presented at the European Congress of Endocrinology (2020) examined vitamin D status in Addison's disease patients and found that there was a significant difference in vitamin D level between patients previously supplementing and non-supplementing. In 70% of patients who supplemented 2000 IU vitamin D prior to admission to hospital, supplementation did not provide adequate vitamin D levels. The study demonstrated a high incidence of vitamin D deficiency and a significant correlation between low levels of vitamin D and severe fatigue as well as limited exercise capacity in Addison's disease patients. Further studies are needed to clarify if impaired vitamin D level is a causal factor in the pathogenesis of the disease and to assess if supplementation improves quality of life. This evidence is preliminary and derives from a conference abstract, not a full peer-reviewed trial.
Corticosteroids, drugs often used in the treatment of Addison's disease, can deplete vitamin D, thus testing vitamin D levels can allow for proper supplementation.
6. Nutrients, Herbs, and Natural Ingredients Studied in Relation to Addison's Disease
6.1 Dehydroepiandrosterone (DHEA)
Scientific evidence (clinical research):
Dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS) are the major circulating adrenal steroids and substrates for peripheral sex hormone biosynthesis. In Addison's disease, glucocorticoid and mineralocorticoid deficiencies require lifelong replacement, but the associated near-total failure of DHEA synthesis is not typically corrected.
Addison's disease results in deficiency of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S). There is considerable debate about the specific effects of DHEA deficiency on energy level and mood.
A randomized, double-blind, crossover trial published in the Journal of Clinical Endocrinology & Metabolism (2000) studied 39 patients with Addison's disease who received 50 mg oral DHEA daily for 12 weeks. In both sexes, psychological assessment showed significant enhancement of self-esteem with a tendency for improved overall well-being. Mood and fatigue also improved significantly, with benefit being evident in the evenings. No effects on cognitive or sexual function, body composition, lipids, or bone mineral density were observed.
A larger, 12-month, double-blind randomized controlled trial (Gurnell et al., J Clin Endocrinol Metab, 2008) enrolled 106 subjects with Addison's disease and randomized them to 50 mg/day of micronized DHEA or placebo. Circulating DHEAS and androstenedione rose significantly in both sexes, with testosterone increasing to low normal levels only in females. DHEA reversed ongoing loss of bone mineral density at the femoral neck (P < 0.05) but not at other sites, and enhanced total body and truncal lean mass.
However, results across studies are not uniform. Earlier studies by Arlt et al. (1999) and Achermann and Silverman (2001) found improvements in well-being and libido after DHEA administration, yet a subsequent study suggested no significant differences in mood or quality-of-life domains assessed between Addison's patients and comparison groups. Patients with Addison's disease on optimal glucocorticoid and mineralocorticoid replacement therapy still report a reduced quality of life when compared with normal individuals. Evidence for DHEA in Addison's is considered preliminary to moderate, with mixed results particularly regarding psychological outcomes; no large-scale phase III trials have established definitive clinical practice guidelines.
6.2 Licorice Root (Glycyrrhiza glabra)
Traditional use:
In the British Herbal Pharmacopoeia and the British Herbal Compendium, licorice is described as an adrenal agent and adrenocorticotropic (which herbalists regard as adrenal supportive) and indicated for primary adrenocortical insufficiency and autoimmune Addison's disease. In the 1950s, licorice extract was found to be a successful medical treatment for some cases of Addison's disease. Patients could be maintained on 3β60 g/day of extract; the lower dosage was used when the disease was controlled.
Scientific evidence and mechanism:
Glycyrrhizin metabolites inhibit type 2 11Ξ²-hydroxysteroid dehydrogenase (11Ξ²-HSD2), which decomposes cortisol into inactive cortisone in the distal nephron, thereby inducing mineralocorticoid receptor activity. Researchers have demonstrated the ability of licorice to treat adrenal insufficiency as well as stress intolerance via enhancement of the adrenal cortisol response. Glycyrrhiza inhibits 11-beta-hydroxysteroid dehydrogenase, the enzyme responsible for inactivating cortisol, and as a result may elevate abnormally low cortisol levels. Glycyrrhizin and glycyrrhizic and glycyrrhetinic acids have each been shown to inhibit the 11-Ξ²-HSD enzymes, thereby allowing cortisol to bind mineralocorticoid receptors. These compounds can also have direct ligand effects on mineralocorticoid and glucocorticoid receptors.
Patients with Addison's disease co-administered a licorice supplement with their cortisol replacement therapy have shown increased cortisol availability in some studies. The evidence for licorice root specifically in Addison's disease is predominantly mechanistic and derived from small or historically reported studies; rigorous randomized controlled trials in diagnosed primary adrenal insufficiency are lacking.
Safety concerns: Hypokalemia or pseudoaldosteronism is one of the most frequent side effects of licorice intake. Licorice has been known for decades to cause mineralocorticoid-like adverse effects including hypertension, edema, heart failure, or hypokalemia, even though patients have low circulating levels of aldosterone. Recent studies revealed that licorice inhibits the enzyme activity of 11Ξ²-HSD2, resulting in a pathological state similar to mineralocorticoid excess, named apparent mineralocorticoid excess state (AME). These adverse effects are particularly significant in the context of Addison's disease because the condition itself involves complex electrolyte imbalances.
6.3 Ashwagandha (Withania somnifera)
Traditional use:
Ashwagandha (Withania somnifera), a well-established herb in Ayurvedic medicine, is increasingly researched for its adaptogenic properties and regulatory roles in neuroimmune processes.
Scientific evidence and mechanism:
Research on ashwagandha integrates mechanistic, preclinical, and clinical evidence on its immunomodulatory, neuroprotective, psychiatric, sleep-regulating, and anti-inflammatory activities, with emphasis on its bioactive compounds such as withanolides, sitoindosides, and alkaloids. Such compounds modulate the hypothalamic-pituitary-adrenal (HPA) axis, inhibit NF-ΞΊB, induce Nrf2 activation, and affect GABAergic signaling, collectively contributing to its anti-inflammatory, antioxidant, and anxiolytic actions.
Clinical trials with standardized ashwagandha extracts have shown reductions in stress-related biomarkers, along with improvements in cognitive performance, sleep quality, and mood parameters. However, the review emphasizes methodological shortcomings, such as heterogeneity in the preparation of extracts, small sample sizes, variability in endpoints, and possible funding-related biases. No clinical trials have specifically studied ashwagandha in patients with confirmed Addison's disease; evidence is largely derived from stress-related research in healthy or subclinically stressed populations.
6.4 Adaptogens: Rhodiola rosea, Panax ginseng, and Eleutherococcus senticosus
Traditional use:
In Ayurvedic and Traditional Chinese Medicine, adaptogens such as Rhodiola rosea, Withania somnifera (Ashwagandha), Panax ginseng, and Eleutherococcus senticosus have been reported to modulate the HPA axis, balance cortisol levels, and improve energy metabolism.
Scientific evidence:
These adaptogens are believed to help modulate stress response systems, support adrenal function, and improve resilience to chronic stress. Research explores the pathophysiology of adrenal insufficiency, mechanisms of action of key adaptogenic herbs, and available clinical and preclinical evidence supporting their use. While preliminary studies suggest adaptogens may enhance adrenal health and stress adaptation, more rigorous clinical trials are needed to confirm efficacy and establish standardized guidelines. Future research should focus on long-term safety, optimal dosages, and integration with traditional therapies. Evidence in the specific context of diagnosed Addison's disease (primary adrenal insufficiency) is very limited; most available data relate to general stress or hypothalamic-pituitary-adrenal axis modulation in otherwise healthy individuals.
6.5 Vitamin C (Ascorbic Acid)
Mechanistic and traditional context:
The adrenal glands are among the organs with the highest concentration of vitamin C in the body. Adrenal glands contain 20β150 times more vitamin C than most body tissues, making it an essential cofactor for cortisol synthesis. Pantothenic acid (B5) is the rate-limiting nutrient in the same cortisol pathway, and deficiency of either impairs adrenal output.
Vitamin C is a powerful antioxidant known for immune support and recovery from illness. It also plays a key role in managing stress by balancing cortisol production and adrenal health. Research suggests it may help lower cortisol, reduce inflammation, and block histamine formation, supporting stress resilience and immune balance. It should be noted that this evidence pertains primarily to adrenal function under stress conditions in healthy or non-Addison's populations; no dedicated clinical trials have examined vitamin C supplementation outcomes specifically in Addison's disease patients. Evidence for direct therapeutic benefit in Addison's disease is weak and indirect.
6.6 Pantothenic Acid (Vitamin B5)
Mechanistic context:
Pantothenic acid (vitamin B5) plays a role in the synthesis and maintenance of coenzyme A (CoA), a crucial cofactor for many biological enzymatic reactions and a primary component of lipid and carbohydrate metabolism. Pantothenic acid is thought to be needed to maintain normal adrenal structure and function, as the administration of pantothenic acid to deficient animals improves adrenal function. Current evidence is largely from animal models, and no clinical trials specifically in Addison's disease have been published.
6.7 Magnesium
Magnesium is essential for relaxation, sleep, stress relief, and adrenal health. Deficiency is common and may increase stress, anxiety, and adrenal dysfunction. It helps balance cortisol, lower histamine, and reduce inflammation. Magnesium is involved in over 300 biochemical reactions in the body. This nutrient is required for the adrenal glands' creation of neurotransmitters as well as the proper functioning of the HPA axis. As with vitamin C, evidence linking magnesium supplementation to clinical improvement specifically in Addison's disease is not established in controlled human trials; the available literature addresses general adrenal function and HPA axis health rather than primary adrenal insufficiency.
6.8 B Vitamins
B vitamins such as B12, B6, B2, B3, and B9 are necessary for a variety of bodily functions including preventing free radical damage, supporting the health of red blood cells, and promoting good cholesterol. Additionally, B vitamins are associated with reducing stress levels as they can significantly improve mood and cognitive performance. Improved mood and stability allow the body and mind to better deal with stressors. No clinical trials have been conducted specifically evaluating B vitamin supplementation outcomes in Addison's disease populations.
6.9 Vitamin D
There are authoritative studies that demonstrate vitamin D's activity in vitro and in vivo on carcinogenesis, inflammation, autoimmunity, and endocrinopathies. Its role has been studied in type 1 and type 2 diabetes mellitus, in Hashimoto or Graves' thyroiditis, and even in adrenal gland diseases. Several studies demonstrate possible correlations between vitamin D and Addison's disease, Cushing disease, hyperaldosteronism, or adrenocortical tumors. Supplemental vitamin D can aid in lowering inflammation and regulating the immune response, two mechanisms that are often altered by HPA dysfunction. This evidence remains preliminary and does not yet establish specific supplementation protocols for Addison's disease outside of the general indication of correcting deficiency.
7. Dietary and Lifestyle Factors
7.1 Sodium Intake
Because of a disruption in hormone levels caused by damage to the adrenal glands, people with Addison's disease need to eat foods high in sodium and low in potassium. Doctors do not prescribe a single specific diet for all individuals with Addison's disease. Instead, dietary recommendations aim to manage electrolyte imbalances and adapt to increased cortisol and aldosterone needs during times of illness or stress.
7.2 Potassium Awareness
To keep electrolytes balanced, people with Addison's may need to eat more sodium, like during stress or when sweating a lot. It is also important to watch potassium levels to avoid excess potassium.
7.3 Hydration
Dehydration can worsen dizziness, fatigue, and low blood pressure. Sipping fluids regularly throughout the day rather than relying on large amounts at once is advisable. Some people benefit from electrolyte-containing drinks that include sodium and potassium. Caffeine and alcohol should be limited, as both can contribute to dehydration.
7.4 Blood Sugar Regulation Through Diet
Prolonged fasting or skipping meals exacerbates glucose depletion due to reduced substrate availability for gluconeogenesis and glycogenolysis. The case report published in a peer-reviewed journal noted that a patient with recurrent nocturnal hypoglycemia in Addison's disease responded favourably to a late evening low-glycaemic-index snack incorporating fat, with associated improvement in morning fatigue, illustrating that dietary timing and composition may have clinically meaningful effects on glucose regulation in this condition.
7.5 Bone Health Dietary Support
A person with Addison's disease may benefit from a high sodium diet, following a doctor's guidance. They may also benefit from eating more foods that contain calcium and vitamin D to help support bone health. Recent realization of physiologic cortisol production rate has revised downwards glucocorticoid replacement dosages. New research has emerged suggesting complex interplay between sodium and calcium homeostasis under the influence of mineralocorticoid and parathyroid hormone that may impact bone health.
7.6 Stress Management and Physical Activity
With Addison's disease, the body cannot increase cortisol output during illness or stress. This makes stress management and awareness especially important. Physiological or psychological stressors, such as illness, surgery, trauma, or emotional distress, increase cortisol requirements and exacerbate adrenal insufficiency, leading to hypoglycemia. Intense or prolonged physical activity increases glucose utilization, exacerbating hypoglycemia in individuals with impaired cortisol secretion. These observations from the clinical literature indicate that physical and psychological stress management are relevant adjunctive concerns for individuals with Addison's disease.
7.7 Overall Dietary Pattern
A balanced diet that includes a variety of whole foods from different food groups, such as fruits, vegetables, lean proteins, whole grains, and healthy fats, is generally recommended. No specific therapeutic diet has been validated in randomized trials for Addison's disease; guidance is based on the known physiological consequences of aldosterone and cortisol deficiency rather than on prospective nutritional intervention studies.
8. Relationship to Other Autoimmune and Endocrine Conditions
The presence of Addison's disease in addition to autoimmune thyroid disease, type 1 diabetes, or both, is called autoimmune polyendocrine syndrome type 2. People who have autoimmune polyendocrine syndrome, a rare inherited condition in which the immune system mistakenly attacks many tissues and organs, are much more likely to have Addison's disease. Mucous membranes, adrenal glands, and parathyroid glands are commonly affected by this syndrome, though it can affect other types of tissues and organs.
The co-occurrence of multiple autoimmune diseases substantially complicates nutritional management, because conditions such as Hashimoto's thyroiditis, type 1 diabetes mellitus, and pernicious anemia each carry their own nutritional implications (e.g., iodine, carbohydrate distribution, B12 absorption) that may interact with the electrolyte and cortisol-related requirements of Addison's disease.
9. Evidence Summary and Research Gaps
The following table summarizes the level of evidence for the most studied nutritional and natural-health interventions in the context of Addison's disease:
- Sodium supplementation: Well-supported physiologically and by clinical consensus; required to compensate for aldosterone deficiency. No randomized trials comparing specific sodium intake strategies.
- DHEA: Evidence from multiple small-to-medium randomized controlled trials (strongest evidence level among natural interventions discussed). Benefits shown for mood, fatigue, and bone mineral density at the femoral neck. Results are mixed and do not extend to all outcomes. DHEA is not approved as a pharmaceutical intervention in most jurisdictions.
- Vitamin D: Observational data suggest high prevalence of deficiency in Addison's disease patients and correlation with fatigue; causal and interventional evidence is preliminary. Correction of clinical deficiency is widely recommended.
- Calcium: Supported by indirect evidence related to corticosteroid-induced bone loss; no clinical trials specific to Addison's disease.
- Licorice root (Glycyrrhiza glabra): Mechanism well-characterized at the enzyme level (11Ξ²-HSD2 inhibition); historical case reports and traditional pharmacopoeial listings exist. Modern randomized trial evidence in diagnosed Addison's disease is absent. Significant adverse event risk (hypokalemia, hypertension) exists, particularly problematic given the existing electrolyte imbalances of the condition.
- Ashwagandha, Rhodiola, Panax ginseng, Eleutherococcus: General adaptogenic evidence from studies in non-Addison's populations; no clinical trials in diagnosed primary adrenal insufficiency. Evidence for adrenal-specific benefit is preliminary and largely preclinical.
- Vitamin C, B5, Magnesium, B vitamins: Evidence is mechanistic and drawn from general adrenal biology or animal studies. No clinical trials in Addison's disease populations. Correction of any deficiency is considered generally sound; claims for benefit beyond deficiency correction are not supported by clinical evidence in this population.
References
Go back